Envision Healthcare could resume its upward trend after recent losses.

According to Surperformance© ratings, the group has strong fundamentals, both in terms of business predictability and valuation. In addition, analysts have been revising upward its earnings estimates and nowadays expect a profit of $0.88 per share for the current year. Debts reductions may imply lower leverage levels in a three-year horizon.

Technically, the ascending triangle pattern suggest prices rises. In the short term, a sharp decline led the share close to the USD 33.9 support, a key level that may now push prices toward higher levels as it also matches with the lower bound of the bullish configuration. Therefore, if a technical rebound takes place the target could be fixed near the USD 36.6 weekly resistance.

Consequently, long positions should be opened at current prices, looking then for the USD 36.6 level. A stop-loss order may be set below the USD 33.9 support.